<SEC-DOCUMENT>0001437749-20-006071.txt : 20200325
<SEC-HEADER>0001437749-20-006071.hdr.sgml : 20200325
<ACCEPTANCE-DATETIME>20200325095515
ACCESSION NUMBER:		0001437749-20-006071
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200325
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200325
DATE AS OF CHANGE:		20200325

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ULTRALIFE CORP
		CENTRAL INDEX KEY:			0000875657
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		IRS NUMBER:				161387013
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20852
		FILM NUMBER:		20740305

	BUSINESS ADDRESS:	
		STREET 1:		2000 TECHNOLOGY PARKWAY
		CITY:			NEWARK
		STATE:			NY
		ZIP:			14513
		BUSINESS PHONE:		3153327100

	MAIL ADDRESS:	
		STREET 1:		2000 TECHNOLOGY PARKWAY
		CITY:			NEWARK
		STATE:			NY
		ZIP:			14513

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ULTRALIFE BATTERIES INC
		DATE OF NAME CHANGE:	19940224
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ulbi20200325_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html><head>
	<title>ulbi20200325_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 3/25/2020 1:36:05 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; padding:0in .1in;">
<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>UNITED STATES</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Washington, D.C.&nbsp;20549</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:18pt;margin:0pt;text-align:center;"><b>FORM 8-K</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>CURRENT REPORT</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>March 25, 2020</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Date of Report (Date of Earliest Event Reported)</p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:18pt;margin:0pt;text-align:center;"><b>ULTRALIFE CORPORATION</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Exact name of registrant as specified in its charter)</p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Delaware</b></p>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>000-20852</b></p>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>16-1387013</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(State of incorporation)</p>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Commission File Number)</p>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(IRS Employer Identification No.)</p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>2000 Technology Parkway, Newark, New York 14513</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Address of principal executive offices) (Zip Code)</p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(315) 332-7100</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Registrant&#8217;s telephone number, including area code)</p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>None</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Former name or former address, if changed since last report)</p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Securities registered pursuant to Section 12(b) of the Act:</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:33.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Common Stock, $0.10 par value per share</b></p>
			</td>
			<td style="vertical-align:bottom;width:33.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>ULBI</b></p>
			</td>
			<td style="vertical-align:bottom;width:33.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>NASDAQ</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Title of each class)</p>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Trading Symbol)</p>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Name of each exchange on which registered)</p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9744; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9744; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9744; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&nbsp;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:middle;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#9744; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging Growth Company &#9744;</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;&nbsp;</b></p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Ite</b><b>m </b><b>8.01 Other Events</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In a press release dated March 25, 2020, Ultralife Corporation (NASDAQ: ULBI) made publicly available a letter to its employees, customers, suppliers, and shareholders regarding its business operations amid the COVID-19 pandemic.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>I</b><b>tem 9.01 </b><b>Financial Statements, Pro Forma Financials and Exhibits</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">(d) Exhibits.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="margin-left:1.2%;width:98.8%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:11.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Exhibit</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Number</b></p>
			</td>
			<td style="vertical-align:bottom;width:3.9%;">&nbsp;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:64.4%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Exhibit Description</b></p>
			</td>
			<td style="vertical-align:bottom;width:20.1%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:11.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">99.1</p>
			</td>
			<td style="vertical-align:top;width:3.9%;">&nbsp;</td>
			<td style="vertical-align:top;border-bottom: 1px #000000;;width:64.4%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><a href="ex_178849.htm" style="-sec-extract:exhibit;">Press Release of Ultralife Corporation dated March 25, 2020</a></p>
			</td>
			<td style="vertical-align:top;width:20.1%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>SIGNATURES</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="vertical-align: bottom; width: 50%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Date: March 25, 2020</p>
			</td>
			<td style="vertical-align: bottom; width: 3%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 47%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-transform:uppercase;"><b>ULTRALIFE Corporation</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&nbsp;</td>
			<td style="vertical-align: top; width: 3%;">&nbsp;</td>
			<td style="vertical-align: top; width: 47%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&nbsp;</td>
			<td style="vertical-align: top; width: 3%;">&nbsp;</td>
			<td style="vertical-align: top; width: 47%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&nbsp;</td>
			<td style="vertical-align: top; width: 3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">By:</p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 47%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">/s/ Philip A. Fain</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&nbsp;</td>
			<td style="vertical-align: top; width: 3%;">&nbsp;</td>
			<td style="vertical-align: top; border-bottom: 1px rgb(0, 0, 0); width: 47%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Philip A. Fain</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&nbsp;</td>
			<td style="vertical-align: top; width: 3%;">&nbsp;</td>
			<td style="vertical-align: top; width: 47%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Chief Financial Officer and Treasurer</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&nbsp;</td>
			<td style="vertical-align: top; width: 3%;">&nbsp;</td>
			<td style="vertical-align: top; width: 47%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&nbsp;</td>
			<td style="vertical-align: top; width: 3%;">&nbsp;</td>
			<td style="vertical-align: top; width: 47%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_178849.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_178849.htm</title>

	<!-- Generated by ThunderDome Portal - 3/25/2020 1:31:17 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; padding:0in .1in;">
<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: right;"><b>Exhibit 99.1</b></p>

<div><img alt="" src="logo01.jpg"></div>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:center;"><b>Ultralife Corporation</b><b> Issues Letter to Stakeholders Regarding Business </b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:center;"><b>Operations in Response to COVID-19 </b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:7.2pt;margin-right:5.75pt;margin-top:0pt;text-align:justify;">NEWARK, N.Y. &#8211; March 25, 2020 -- Ultralife Corporation (NASDAQ: ULBI)<b> </b>today issued a letter to its employees, customers, suppliers, and shareholders regarding its business operations amid the COVID-19 pandemic.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:7.2pt;margin-right:5.75pt;margin-top:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:7.2pt;margin-right:5.75pt;margin-top:0pt;text-align:justify;">The letter follows.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:7pt;margin-right:5.8pt;margin-top:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:5.75pt;margin-top:0pt;text-align:justify;">As we continue to monitor the evolving impact of the COVID-19 pandemic, we have taken the necessary steps to safeguard the health and well-being of our employees in accordance with protocols established by public health organizations and state and local public health departments while ensuring an uninterrupted flow of our mission critical products serving medical device, first responder, public safety, energy and national security customers. We have received letters from several large customers serving these essential markets thanking us for our efforts and confirming their dependence on our continued supply of products during this critical time.<b> </b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:5.75pt;margin-top:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:5.75pt;margin-top:0pt;text-align:justify;">Based on the recent State and Federal government mandates, Ultralife Corporation will maintain normal operations across all locations during the COVID-19 emergency response. In accordance with the Executive Order from the Governor of the State of New York, Ultralife falls under the criteria of an &#8220;Essential Supplier&#8221; due to our production and supply of battery and energy products that support ventilators, respirators, and other vital medical, surgical and life-saving equipment, and is a Federal government contractor/subcontractor to the U.S. Military, other Federal agencies as well as first responders, for a variety of products that support tactical communications, emergency equipment, cybersecurity solutions, and other strategic requirements. Ultralife also falls under the criteria of a &#8220;Critical Infrastructure Industry&#8221; as defined by the Department of Homeland Security, and has a special responsibility to maintain our normal work schedule in supporting the essential products and services required to meet national security commitments to the Federal Government and U.S. Military.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:11.5pt;margin-top:0pt;text-align:justify;">We are collectively rising to meet the challenges presented by this unprecedented pandemic and remain dedicated to working closely with our customers and suppliers to support our country&#8217;s public health and national security needs.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:7pt;margin-right:11.5pt;margin-top:0pt;text-align:justify;text-indent:29pt;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:7pt;margin-right:11.5pt;margin-top:0pt;text-align:justify;text-indent:29pt;"><b>Thank You, </b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:7pt;margin-right:11.65pt;margin-top:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div style="margin-left: 36pt;"><img alt="" src="sig01.jpg"></div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:7pt;margin-right:11.65pt;margin-top:0pt;text-align:justify;text-indent:29pt;"><b>Michael D. Popielec,</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:7pt;margin-right:11.65pt;margin-top:0pt;text-align:justify;text-indent:29pt;"><b>President &amp; Chief Executive Officer, Ultralife Corporation</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>About Ultralife Corporation</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Headquartered in Newark, New York, the Company's business segments include Battery &amp; Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit <u>www.ultralifecorporation.com</u>.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include potential reductions in revenues from key customers, acceptance of our new products on a global basis and uncertain global economic conditions. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife&#8217;s financial results is included in Ultralife&#8217;s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="1" style="vertical-align: top; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:justify;"><b>Company Contact:</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="1" style="vertical-align: top; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:justify;"><u>Ultralife Corporation</u></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="1" style="vertical-align: top; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:justify;">Philip A. Fain</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="1" style="vertical-align: top; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:justify;">(315) 210-6110</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="1" style="vertical-align: top; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:justify;"><u>pfain@ulbi.com</u></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 77.8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:justify;">&nbsp;</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:justify;"><b>Investor Relations Contact:</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 77.8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:justify;"><u>LHA</u></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 77.8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:justify;">Jody Burfening</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 77.8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:justify;">(212) 838-3777</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 77.8%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:justify;"><u>jburfening@lhai.com</u></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo01.jpg
<TEXT>
begin 644 logo01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M1]+U#5KZ9;>QTNSNM0O;AV")!9V4$ES=3.QX"Q01O(Q(( 4D@@8K^>?XN_\
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MMXYT'1-<U6^LKJ*UTWPO;S_VGXPU6\N"#Y-MIOAG2]3NIYSDQGS6^;8* /\
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M#=\1O^#4S]NCP[KUY:^%Y-?U#25GD6U?6?AMK5_=QQ*_[L27_@+4?%VD7[*
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LA[4FT#HH_(>Y_F2?Q/K110 8'H/RI2,]1GZC\/Y'%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>sig01.jpg
<TEXT>
begin 644 sig01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M6D$FI^%/$L>D7MX^A>)-.CN;:2_T/5%M=3LTN('N+6-94+=;0 4444 %%%%
M!1110!^;'_!63]H3QO\  #]B[QW;?!NXGB_:._:$\0>#?V3_ -F**SD$-^/C
MQ^T9KL'PX\':Y9RF2,0GP%:ZMK'Q)O+EF*6NF^#KRXD5TC*-X!^T]XA\!_\
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MFM^+/VE_$4#VDOVB5+G7_B?XDUPZ@7D9U9KJ682DR#]/-$^('PS^$7_!8/\
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M?\,?H)^WQ^VMXU_9'\0?L6>"_AQ\'H?C3XU_:]_:_P#A]^S9;Z%-XNA\)?\
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M:VR5.2DDTK+5R?P)1LW=M6[:/5MI)-M!\GZ=3Y5_X-+/V5OB?\%O^">'B_\
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ME6'[\JH484 #K@4M4ZD_>2LN=1C*UU[L.5)?-+6_7Y6#_.>_:8_X)P?MM?\
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MY_%#X0^%M6TCP)8>*?!VG^(-*NY]&;1/$&DSZ' 5;^LH@$@D<KG!YXSUH"@
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MK3DN5N]HQ4=+)13:]Z?+%))S<I:)WO>XHI;7OJW=MZOU;W]%VV/$_CY^S?\
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$ '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
